[1] |
.
[J]. Clinical Focus, 2021, 36(1): 70-74.
|
[2] |
Ma Xiaojuan, Zhang Xu, Jiang Yong.
Etiological analysis in 111 patients with ascites
[J]. Clinical Focus, 2016, 31(2): 211-213.
|
[3] |
.
Hyperthermic intraperitoneal chemotherapy on tumor markers CA125 and CA19-9 level in patients with malignant ascites
[J]. Clinical Focus, 2015, 30(10): 1156-1159.
|
[4] |
.
[J]. Clinical Focus, 2012, 27(6): 488-0.
|
[5] |
.
[J]. CLINICAL FOCUS, 2011, 26(9): 794-795.
|
[6] |
.
[J]. CLINICAL FOCUS, 2009, 24(6): 513-515.
|
[7] |
.
[J]. CLINICAL FOCUS, 2008, 23(18): 1356-1357.
|
[8] |
.
[J]. CLINICAL FOCUS, 2007, 22(18): 1355-1355.
|
[9] |
.
[J]. CLINICAL FOCUS, 2006, 21(11): 813-814.
|
[10] |
.
[J]. CLINICAL FOCUS, 2005, 20(20): 0-0.
|
[11] |
.
[J]. CLINICAL FOCUS, 2005, 20(12): 689-690.
|
[12] |
.
[J]. CLINICAL FOCUS, 2003, 18(22): 1288-1288.
|
[13] |
.
[J]. CLINICAL FOCUS, 2003, 18(12): 707-708.
|
[14] |
.
[J]. CLINICAL FOCUS, 2002, 17(22): 1362-1363.
|
[15] |
.
[J]. CLINICAL FOCUS, 2002, 17(22): 1363-1365.
|